Release Date: 25/03/11 15:22 Summary: Announcement of buy-back - Appendix 3C Price Sensitive: Yes Download Document 81.62KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling